Stock comparison
Bioventus
BVS$1.19BHealthcare Market cap, Sector
Sanofi Consumer Healthcare India Limited
SANOFICONR.BO$104.05BHealthcare Market cap, Sector
Overall winner
Sanofi Consumer Healthcare India Limited
BVS 07 SANOFICONR.BO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
BVS0wins
7winsSANOFICONR.BO
34F
B78
50D
A89
39F
B83
27F
B77
24F
A91
36F
A86
32F
A85
Side-by-side metrics
| Metric | BVS | SANOFICONR.BO |
|---|---|---|
| Market cap | $1.19B | $104.05B Winner |
| P/E (TTM) | Winner: 25.0x | 44.0x |
| EV/EBIT | Winner: 12.0x | 31.7x |
| ROIC (TTM) | 11.77% | 59.15% Winner |
| Gross margin | 67.78% | 68.13% Winner |
| Net margin | 4.94% | 27.35% Winner |
| Revenue CAGR 5y | 7.15% | 27.01% Winner |
| EPS CAGR 5y | - | 20.67% |
| Debt / Equity | 0.1x | 0.1x Winner |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BVS leads on
- EV/EBIT12.0xvs 31.7x+62%
- P/E (TTM)25.0xvs 44.0x+43%
SANOFICONR.BO leads on
- Market cap$104.05Bvs $1.19B+99%
- Net margin27.35%vs 4.94%+82%
- ROIC (TTM)59.15%vs 11.77%+80%
- Revenue CAGR 5y27.01%vs 7.15%+74%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.